Peter A. Thompson - 10 Jun 2024 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role
Director, 10%+ Owner
Signature
/s/ John R. Moore Attorney-in-Fact for Peter Thompson M.D.
Issuer symbol
EWTX
Transactions as of
10 Jun 2024
Net transactions value
$0
Form type
4
Filing time
12 Jun 2024, 19:33:48 UTC
Previous filing
20 May 2024
Next filing
17 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EWTX Stock Options (Right to buy) Award $0 +20,594 $0.000000 20,594 10 Jun 2024 Common Stock 20,594 $17.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the Stock Options granted on June 10, 2024 will become vested on the earlier of (i) June 10, 2025 or (ii) the business day prior to the date of the 2025 annual meeting of stockholders.